35267-14-2Relevant articles and documents
PHARMACEUTICAL COMPOUNDS AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19)
-
Page/Page column 275, (2020/07/04)
Provided are USP19 inhibitors, methods of treating obesity, metabolic syndrome and/or diabetes using the USP19 inhibitor compounds, as well as those compounds for use in methods of treating obesity, metabolic syndrome and/or diabetes. Also provided are methods of treating muscular atrophy, for example cachexia or sarcopenia with USP19 inhibitor compounds, plus those compounds for use in methods of treating muscular atrophy.
A fluorescent probe for hypochlorite based on the modulation of the unique rotation of the N-N single bond in acetohydrazide
Long, Lingliang,Wu, Yanjun,Wang, Lin,Gong, Aihua,Hu, Feilong,Zhang, Chi
supporting information, p. 10435 - 10438 (2015/06/25)
Herein, a novel signaling mechanism for constructing fluorescent probes was demonstrated for the first time based on modulation of the unique rotation of the N-N single bond in the acetohydrazide group. According to the new signaling mechanism, a fluorescent probe for hypochlorite was then judiciously developed.